Guangdong Hybribio Biotech (300639.SZ) traded flat 0 % during a 24 hours period ending at 06:41 PM Central Europe on Monday 26th. One Guangdong Hybribio Biotech stock can currently be bought for about CNY 5.83 on popular exchanges. Current supply of Guangdong Hybribio Biotech stocks is 628 mn. Guangdong Hybribio Biotech has a current market capitalization of CNY 3.6 bn and approximately CNY 110.6 mn worth of Guangdong Hybribio Biotech was traded on exchanges in the last 24 hours. Since last month end, Guangdong Hybribio Biotech has traded -7.07 % down. Simple moving average of last 200 days is at CNY 5.69. The highest price of past 52 weeks was recorded at CNY 10.07 on 01/28/2026. 52 weeks low was at CNY 4.75 on 06/29/2026.
Here is how related stocks have performed in the past 24 hours:
Shenzhen Minglida Precisio (301268.SZ) traded flat 0 % and now trades at CNY 11.11. Shenzhen Minglida Precisio has a market capitalisation of CNY 4.4 bn.
Hangzhou Ags Medtech Lt (688581.SS) traded flat 0 % and now trades at CNY 55.76. Hangzhou Ags Medtech Lt has a market capitalisation of CNY 4.4 bn. On October 23, 2026, financing activity across the Shanghai Stock Exchange remained robust, with 3,870 stocks receiving margin purchases. The data highlighted significant inflows into a range of names, including both large‑cap technology and industrial players. While the article lists the top recipients of financing, it does not mention HANGZHOU AGS MEDTECH CO LT. No specific information about the company’s financial performance, share price movement or corporate developments was provided in the source. Consequently, there is no basis for reporting any direct impact on HANGZHOU AGS MEDTECH CO LT in this context.
Ningbo Techmation (603015.SS) traded flat 0 % and now trades at CNY 10.48. Ningbo Techmation has a market capitalisation of CNY 4.4 bn. Current price/earnings ratio for Ningbo Techmation is 113.92.
Shenzhen Bauing Contructio (002047.SZ) traded flat 0 % and now trades at CNY 2.8. Current market capitalisation for Shenzhen Bauing Contructio is CNY 4.4 bn. Current price/earnings ratio for Shenzhen Bauing Contructio is 80.11.
Guangdong Yussen Energy Te (002986.SZ) traded flat 0 % and now trades at CNY 11.02. Current market capitalisation for Guangdong Yussen Energy Te is CNY 4.4 bn. Current price/earnings ratio for Guangdong Yussen Energy Te is 104.33.
About Guangdong Hybribio Biotech
Guangdong Hybribio Biotech Co.,Ltd. is a health care biotechnology company that specializes in conducting research and development, manufacturing, selling, marketing, and providing after-sales technical support for in-vitro diagnostic products. These products are designed for use in hospitals and medical institutes. The company offers a range of in-vitro diagnostic kits for various applications, including human papilloma virus, sexually transmitted diseases, thalassemia, and prenatal neonatal testing. Female sample collection kits, DNA extraction kits such as hepatitis B virus real-time PCR kits and thalassemia gene diagnostic kits, and devices/instruments including flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems are also part of their product portfolio. These products are used in the fields of clinical detection, large scale screening, research, and prenatal and neonatal management. Guangdong Hybribio Biotech Co.,Ltd. serves approximately 25 countries in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company has its main operations in Sheung Wan, Hong Kong, and it is listed on the Shenzhen Stock Exchange. The web address for the company is www.hybribio.cn .
